Recent publications

  1. Shamout S, Anderson K, Baverstock R, Carlson K. Evaluation of surgical approaches for vesicovaginal fistulae repair: the case for transvaginal repair as the gold standard. Int Urogynecol J. 2021 Jun 11. doi: 10.1007/s00192-021-04869-w. PMID: 34115165.
  2. Carlson KV, Rovner ES, Nair KV, Deal AS, Kristy RM, Hairston JC. Persistence with mirabegron or antimuscarinic treatment for overactive bladder syndrome: Findings from the PERSPECTIVE registry study. Low Urin Tract Symptoms. 2021 May 14. doi: 10.1111/luts.12382. PMID: 33987973.
  3. Khan A, Crump RT, Carlson KV, Baverstock RJ. The relationship between overactive bladder and prostate cancer: A scoping review. Can Urol Assoc J. 2021 Feb 12. doi: 10.5489/cuaj.7058. PMID: 33591905.
  4. Yao HH, Hoe V, Crump RT, Sengupta S, O’Connell HE, Carlson KV, Baverstock RJ. Impact of radical prostatectomy on bladder function as demonstrated on urodynamics study – A systematic review. Neurourol Urodyn. 2021 Feb;40(2):582-603. doi: 10.1002/nau.24606. Epub 2021 Jan 21. PMID: 33591905.

  5. Gotto G, Drachenberg DE, Chin J, Casey R, Fradet V, Sabbagh R, Shayegan B, Rendon RA, Danielson B, Camacho F, Zardan A, Plante R, Hew H, Chan K, Feifer A. Real-world evidence in patient-reported outcomes (PROs) of metastatic castrate-resistant prostate cancer (mCRPC) patients treated with abiraterone acetate + prednisone (AA+P) across Canada: Final results of COSMiC. Can Urol Assoc J. 2020 Dec;14(12):E616-E620. doi: 10.5489/cuaj.6388. PMID: 32569568.

  6. Redmond EJ, Nadeau G, Tu LM, Doiron RC, Steele SS, Herschorn S, Locke JA, Maciejewski CC, Dwyer NT, Campeau L, Carlson KV, Rourke KF. Multicentered Assessment of Clinical Outcomes and Factors Associated With Failure of the Adjustable TransObturator Male System (ATOMS). Urology. 2021 Feb;148:280-286. doi: 10.1016/j.urology.2020.09.045. Epub 2020 Nov 10.

  7. Hird AE, Magee DE, Bhindi B, Ye XY, Chandrasekar T, Goldberg H, Klotz L, Fleshner N, Satkunasivam R, Klaassen Z, Wallis CJD. A Systematic Review and Network Meta-analysis of Novel Androgen Receptor Inhibitors in Non-metastatic Castration-resistant Prostate Cancer. Clin Genitourin Cancer. 2020 Oct;18(5):343-350. doi: 10.1016/j.clgc.2020.02.005. Epub 2020 Mar 6. PMID: 32278840.

  8. Xie L, Tapiero S, Flores AR, Armas-Phan M, Limfueco L, Karani R, Jiang P, Cobb KD, Sur RL, Chi T, Landman J, Kaler KS, Clayman RV. Long-Term Antibiotic Treatment Prior to Laparoscopic Nephrectomy for Xanthogranulomatous Pyelonephritis Improves Postoperative Outcomes: Results from a Multicenter Study. J Urol. 2020 Oct 20:101097JU0000000000001429. doi: 10.1097/JU.0000000000001429. Epub ahead of print. PMID: 33080147.

  9. Bhindi B, Graham J, Wells JC, Bakouny Z, Donskov F, Fraccon A, Pasini F, Lee JL, Basappa NS, Hansen A, Kollmannsberger CK, Kanesvaran R, Yuasa T, Ernst DS, Srinivas S, Rini BI, Bowman I, Pal SK, Choueiri TK, Heng DYC. Deferred Cytoreductive Nephrectomy in Patients with Newly Diagnosed Metastatic Renal Cell Carcinoma. Eur Urol. 2020 Oct;78(4):615-623. doi: 10.1016/j.eururo.2020.04.038. Epub 2020 Apr 30. PMID: 32362493.

  10. Packiam VT, Bhindi B. Are We Moving Closer to Accurate Restaging after Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer? Eur Urol. 2020 Sep 23:S0302-2838(20)30711-9. doi: 10.1016/j.eururo.2020.09.019. Epub ahead of print. PMID: 32980169.

  11. Mossa AH, Galan A, Cammisotto PG, Velasquez Flores M, Shamout S, Barcelona P, Saragovi HU, Campeau L. Antagonism of proNGF or its receptor p75NTR reverses remodelling and improves bladder function in a mouse model of diabetic voiding dysfunction. Diabetologia. 2020 Sep;63(9):1932-1946. doi: 10.1007/s00125-020-05222-4. Epub 2020 Jul 22. PMID: 32699962.

  12. Cheung DC et al. Canadian Update on Surgical Procedures (CUSP) Urology Group. Canadian Update on Surgical Procedures (CUSP) Urology Group consensus for intraoperative hemostasis during minimally invasive partial nephrectomy. Can Urol Assoc J. 2020 Sep;14(9):E387-E393. doi: 10.5489/cuaj.6579. PMID: 32569571; PMCID: PMC7492033.

  13. Brennand EA et al. Two Intraoperative Techniques for Midurethral Sling Tensioning: A Randomized Controlled Trial. Obstet Gynecol. 2020 Sep;136(3):471-481. doi: 10.1097/AOG.0000000000004027. PMID: 32769657; PMCID: PMC7431154.

  14. Mossa AH, Cammisotto PG, Shamout S, Campeau L. Imbalance of nerve growth factor metabolism in aging women with overactive bladder syndrome. World J Urol. 2020 Sep 1. doi: 10.1007/s00345-020-03422-6. Epub ahead of print. PMID: 32870355.

  15. Shamout S, Carlson K, Brotherhood HL, Crump T, Baverstock R. Incidence and predictors of early and late hospital readmission after transurethral resection of the prostate: a population-based cohort study. BJU Int. 2020 Aug 13. doi: 10.1111/bju.15191. Epub ahead of print. PMID: 32790101.

  16. Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ. Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin. Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183228. doi: 10.1016/j.bbamem.2020.183228. Epub 2020 Feb 29. PMID: 32126228.

  17. Young CD, Walker AM, Weber BA, Spencer AO. Quality improvement assessment of a bianchi-technique pediatric orchiopexy perioperative pain management pathway. J Pediatr Urol. 2020 Aug;16(4):461.e1-461.e9. doi: 10.1016/j.jpurol.2020.06.013. Epub 2020 Jun 18. PMID: 32698984.

  18. Shiff B, Breau RH, Patel P, Mallick R, Tanguay S, So A, Lavallée L, Moore R, Rendon R, Kapoor A, Pouliot F, Finelli A, Bhindi B, Lattouf JB, Basappa N, Wood L, Heng D, Bjarnason G, Drachenberg D. Impact of Time-To-Surgery and Surgical Delay on Oncologic Outcomes for Renal Cell Carcinoma. J Urol. 2020 Jul 2:101097JU0000000000001230. doi: 10.1097/JU.0000000000001230. Epub ahead of print. PMID: 32614274.

  19. Yang DY, Potretzke TA, Miest TS, Bhindi B, Lohse CM, Cheville JC, King BF, Boorjian SA, Leibovich BC, Thompson RH, Potretzke AM. Timing and distribution of early renal cell carcinoma recurrences stratified by pathological nodal status in M0 patients at the time of nephrectomy. Int J Urol. 2020 Jul;27(7):618-622. doi: 10.1111/iju.14261. Epub 2020 May 18. PMID: 32424856.

  20. Campeau L, Shamout S, Baverstock RJ, Carlson KV, Elterman DS, Hickling DR, Steele SS, Welk B. Canadian Urological Association Best Practice Report: Catheter use. Can Urol Assoc J. 2020 Jul;14(7):E281-E289. doi: 10.5489/cuaj.6697. PMID: 32432528; PMCID: PMC7337716.

  21. Gotto G et al. Real-world evidence in patient-reported outcomes (PROs) of metastatic castrate-resistant prostate cancer (mCRPC) patients treated with abiraterone acetate + prednisone (AA+P) across Canada: Final results of COSMiC. Can Urol Assoc J. 2020 Jun 16. doi: 10.5489/cuaj.6388. Epub ahead of print. PMID: 32569568.

  22. Assem H, Broeke N, Coleman L, Gotto G, Bismar TA. Case – Highly aggressive urothelial carcinoma of the bladder presenting with solitary metastasis to the phalanx. Can Urol Assoc J. 2020 Jun 5. doi: 10.5489/cuaj.6263. Epub ahead of print. PMID: 32520708.

  23. Patel RM, Limfueco L, Tapiero S, O’Leary M, Cooper V, Parkhomenko E, Kaler KS, Okhunov Z, Regan D, Landman J, Clayman RV. Ureteroscopic Doppler Ultrasonography: Mapping Renal Blood Flow from Within the Collecting System. J Endourol. 2020 Jun;34(6):687-691. doi: 10.1089/end.2019.0884. Epub 2020 Apr 28. PMID: 32212863.

  24. Hermanns T, Savio AJ, Olkhov-Mitsel E, Mari A, Wettstein MS, Saba K, Bhindi B, Kuk C, Poyet C, Wild PJ, Noon A, Bashir S, Juvet T, Rendon RA, Waltregny D, van der Kwast T, Finelli A, Kulkarni GS, Fleshner NE, Lo K, Bapat B, Zlotta AR. A noninvasive urine-based methylation biomarker panel to detect bladder cancer and discriminate cancer grade. Urol Oncol. 2020 Jun;38(6):603.e1-603.e7. doi: 10.1016/j.urolonc.2020.01.007. Epub 2020 Feb 18. PMID: 32081560.

  25. Steinberg RL, Thomas LJ, Brooks N, Mott SL, Vitale A, Crump T, Rao MY, Daniels MJ, Wang J, Nagaraju S, DeWolf WC, Lamm DL, Kates M, Hyndman ME, Kamat AM, Bivalacqua TJ, Nepple KG, O’Donnell MA. Multi-Institution Evaluation of Sequential Gemcitabine and Docetaxel as Rescue Therapy for Nonmuscle Invasive Bladder Cancer. J Urol. 2020 May;203(5):902-909. doi: 10.1097/JU.0000000000000688. Epub 2019 Dec 10. PMID: 31821066.

  26. Mossa AH, Shamout S, Cammisotto P, Campeau L. Urinary metabolomics predict the severity of overactive bladder syndrome in an aging female population. Int Urogynecol J. 2020 May;31(5):1023-1031. doi: 10.1007/s00192-019-04175-6. Epub 2019 Dec 7. PMID: 31813035.

  27. Grivas P, Bismar TA, Alva AS, Huang HC, Liu Y, Seiler R, Alimohamed N, Cheng L, Hyndman ME, Dabbas B, Black PC, Davicioni E, Wright JL, Ornstein MC, Mian OY, Kaimakliotis HZ, Gibb EA, Lotan Y. Validation of a neuroendocrine-like classifier confirms poor outcomes in patients with bladder cancer treated with cisplatin-based neoadjuvant chemotherapy. Urol Oncol. 2020 Apr;38(4):262-268. doi: 10.1016/j.urolonc.2019.11.004. Epub 2019 Dec 4. PMID: 31812633.

  28. Couture F, Finelli A, Tétu A, Bhindi B, Breau RH, Kapoor A, Kassouf W, Lavallée L, Tanguay S, Violette PD, Richard PO. Management of complex renal cysts in Canada: results of a survey study. BMC Urol. 2020 Apr 28;20(1):47. doi: 10.1186/s12894-020-00614-5. PMID: 32345268; PMCID: PMC7189683.

  29. Crump RT, Peterson A, Charbonneau C, Carlson KV, Sutherland JM, Baverstock RJ. Evaluating the measurement properties of the 26-item Expanded Prostate Cancer Index Composite (EPIC-26) with a multicenter cohort. Can Urol Assoc J. 2020 Apr;14(4):111-117. doi: 10.5489/cuaj.5997. Epub 2019 Oct 18. PMID: 31702548; PMCID: PMC7124185.

  30. Tilley D, Remondini T, Van Tuyl J, Pak W, Gotto GT. Temporal Trends in Selecting Patients for Partial Nephrectomy for Small Renal Cell Carcinomas in Alberta, Canada. Res Rep Urol. 2020 Mar 4;12:85-90. doi: 10.2147/RRU.S212584. PMID: 32185151; PMCID: PMC7061720.

  31. Mitchell A, Bolduc S, Moore K, Cook A, Fermin C, Weber B. Use of a magnetic double J stent in pediatric patients: A case-control study at two Canadian pediatric centers. J Pediatr Surg. 2020 Mar;55(3):486-489. doi: 10.1016/j.jpedsurg.2019.03.014. Epub 2019 Mar 28. PMID: 30982535.

  32. Bhindi B, Asante D, Branda ME, Hickson LJ, Mason RJ, Jeffery MM, Boorjian SA, Leibovich BC, Thompson RH. Survival outcomes for patients with surgically induced end-stage renal disease. Can Urol Assoc J. 2020 Mar;14(3):E65-E73. doi: 10.5489/cuaj.6010. Epub 2019 Sep 27. PMID: 31599719; PMCID: PMC7053372.

  33. Wallis CJD, Klaassen Z, Luckenbaugh AN, Laviana AA, Bhindi B. Adjuvant Versus Salvage Radiotherapy Following Radical Prostatectomy: Meta-analysis of the Effect of Comparator Salvage Approach on Study Conclusions. Eur Urol. 2020 Mar;77(3):395-396. doi: 10.1016/j.eururo.2019.11.005. Epub 2019 Nov 14. PMID: 31735431.

  34. Oake JD, Shiff B, Harasemiw O, Tangri N, Ferguson TW, Bhindi B, Saranchuk JW, Bansal RK, Drachenberg DE, Nayak JG. The Comparative Outcomes of Radical Prostatectomy versus Radiotherapy for Non-metastatic Prostate Cancer: A Longitudinal, Population-Based Analysis. J Urol. 2020 Feb 18:101097JU0000000000000805. doi: 10.1097/JU.0000000000000805. Epub ahead of print. PMID: 32068493.

  35. Welk B, Baverstock R. Is there a link between back pain and urinary symptoms? Neurourol Urodyn. 2020 Feb;39(2):523-532. doi: 10.1002/nau.24269. Epub 2020 Jan 3. PMID: 31899561.

  36. Lavallée LT, McAlpine K, Kapoor A, Pouliot F, Mason R, Violette PD, Bansal RK, Richard PO, Karakiewicz PI, Bhindi B, Maloni R, Pautler S, Lattouf JB, Kassouf W, Tanguay S, So A, Rendon RA, Breau RH. Kidney Cancer Research Network of Canada (KCRNC) consensus statement on the role of renal mass biopsy in the management of kidney cancer. Can Urol Assoc J. 2019 Dec;13(12):377-383. doi: 10.5489/cuaj.6176. Epub 2019 Sep 17. PMID: 31799919; PMCID: PMC6892686.

  37. Ahmad AE, Mohammed A, Bhindi B, Richard PO, Fadaak K, Leão R, Finelli A, Fleshner NE, Kulkarni GS. Serum Adipokines as Predictors for the Outcome of Prostate Biopsies at Early Stage Prostate Cancer Diagnosis. Cancer Manag Res. 2019 Nov 29;11:10043-10050. doi: 10.2147/CMAR.S226174. PMID: 31819637; PMCID: PMC6890197.